0001410939-23-000018.txt : 20230227 0001410939-23-000018.hdr.sgml : 20230227 20230227170140 ACCESSION NUMBER: 0001410939-23-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Christine Ann CENTRAL INDEX KEY: 0001903530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 23676299 MAIL ADDRESS: STREET 1: 5 PENN PLAZA, SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_167753524641044.xml FORM 4 X0306 4 2023-01-05 0 0001410939 IVERIC bio, Inc. ISEE 0001903530 Miller Christine Ann C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 1 0 0 0 Common Stock 2023-01-05 4 M 0 5000 A 5000 D Restricted Stock Units 2023-01-05 4 M 0 5000 0 D Common Stock 5000.0 10000 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. On January 5, 2022, the Reporting Person was granted 15,000 restricted stock units, which vest with respect to 1/3rd of the shares subject to the award in annual installments until the third anniversary of the grant date, subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Christine Miller 2023-02-27